Decoding Risk Series — Part 2: Why Medication Leaflets Look So Terrifying

You know the feeling. You open a medication leaflet, and suddenly you’re staring at pages of tiny print and an endless list of side effects that make you wonder, “How is this medication even considered safe?”

In Part 2 of the Decoding Risk series, Danielle Boyle is joined by haematologist Dr Danny Hsu to break down why medication leaflets look the way they do and what patients actually need to understand when reading them.

Together, they unpack:

• how side effects are reported during clinical trials
• why every symptom gets documented, even when it may not be caused by the medication
• what statements like “1 in 9 people experienced this” really mean
• why population statistics are not personal predictions
• and how online forums can sometimes amplify fear and worst-case thinking.

Dr Hsu also shares practical advice on how to navigate medication information more confidently, including what side effects are actually important to focus on, how severity is graded, and the questions patients should ask their healthcare team before starting treatment.

This episode is designed to help patients move from fear to understanding, so treatment decisions feel clearer, calmer, and far less overwhelming.

Support the show

Thanks for listening to Beyond the Count

For more information, resources and lived experiences about Immune Thrombocytopenia (ITP), visit ITPANZ.org.au.

📱 Follow us on social media:
Instagram: @ITP_ANZ
Facebook: facebook.com/ITPANZ
LinkedIn: ITP Australia & New Zealand
YouTube: @ITPANZ

🎧 Subscribe to Beyond the Count on your preferred podcast platform so you never miss an episode.

Do you have feedback or a story to share? We’d love to hear from you. Get in touch at [email protected]